Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

In China, Roche and Swiss Re Offer Insurance to Cover Biologic Drugs

publication date: Nov 14, 2012
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
To increase China sales of its biologic drugs, Roche is using a strategy that works in the west: insurance. The company is working with Swiss Re to offer insurance at a nominal amount to China’s residents. Although China offers a basic level of insurance to its citizens, the plans do not cover Roche’s high-priced cancer drugs. So far, according to a Bloomberg article, six million Chinese have signed up, and ten million are expected before the end of the year. More details....

Stock Symbol: (VX: ROG)

Share this with colleagues:  


This article is available for purchase - please click here for details.


Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Sponsors